UnitedHealth Group reported a strong start to 2019, with significant growth in revenues, earnings per share, and return on equity, alongside strategic initiatives to enhance consumer pharmacy discounts and digital health engagement. However, the potential return of the health insurance tax in 2020 and concerns about radical changes in healthcare policy might temper the initially positive market reaction.

[1]
        